Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Racial Disparities in Pneumococcal Vaccination in Managed Care

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00229762
Recruitment Status : Completed
First Posted : September 30, 2005
Last Update Posted : September 30, 2005
Kaiser Permanente
Information provided by:
Centers for Disease Control and Prevention

Brief Summary:
The goal of the study was to determine effectiveness of a telephone reminder to increase pneumococcal vaccination in a managed care population.

Condition or disease Intervention/treatment Phase
Pneumococcal Disease Prevention Behavioral: phone call from nurses - informational only Not Applicable

Detailed Description:
Patients randomized to the intervention arm received a telephone call from managed care nurses asking about their pneumococcal vaccination status and whether they would like to be vaccinated. We compared six month follow-up of pneumococcal vaccination in electronic medical records for the intervention versus control group. We tested the percent vaccinated in each randomization arm using chi-square tests for proportions.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Enrollment : 7000 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single
Primary Purpose: Educational/Counseling/Training
Official Title: Racial Disparities in Pneumococcal Vaccination in Managed Care: the Effects of Randomized Telephone Outreach
Study Start Date : March 2004
Study Completion Date : June 2005

Primary Outcome Measures :
  1. pneumococcal vaccination coverage

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

- recommended for pneumococcal vaccination according to age or medical comorbidity

Exclusion Criteria:

- already known to have received pneumococcal vaccine

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00229762

Layout table for location information
United States, Georgia
Kaiser Permanente
Atlanta, Georgia, United States, 30333
Sponsors and Collaborators
Centers for Disease Control and Prevention
Kaiser Permanente
Layout table for investigator information
Principal Investigator: Carla A Winston, PhD Centers for Disease Control and Prevention

Layout table for additonal information Identifier: NCT00229762    
Other Study ID Numbers: CDC-NIP-4252
First Posted: September 30, 2005    Key Record Dates
Last Update Posted: September 30, 2005
Last Verified: September 2005
Keywords provided by Centers for Disease Control and Prevention:
pneumococcal vaccination coverage with no disease or efficacy outcomes recorded
Additional relevant MeSH terms:
Layout table for MeSH terms
Pneumococcal Infections
Streptococcal Infections
Gram-Positive Bacterial Infections
Bacterial Infections
Immunologic Factors
Physiological Effects of Drugs